- Home
- RVTY vs BAX Comparison
RVTY vs BAX Comparison
Compare RVTY & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVTY | BAX |
|---|---|---|
| Founded | 1937 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 10.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RVTY | BAX |
|---|---|---|
| Price | $117.74 | $20.07 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 10 |
| Target Price | ★ $113.46 | $25.00 |
| AVG Volume (30 Days) | 1.2M | ★ 8.2M |
| Earning Date | 02-02-2026 | 02-12-2026 |
| Dividend Yield | ★ 0.24% | 0.20% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.99 | N/A |
| Revenue | $2,813,367,000.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $5.30 | $5.22 |
| Revenue Next Year | $3.03 | $1.98 |
| P/E Ratio | $58.51 | ★ N/A |
| Revenue Growth | 3.37 | ★ 3.90 |
| 52 Week Low | $81.36 | $17.40 |
| 52 Week High | $128.29 | $37.74 |
Technical Indicators
Market Signals| Indicator | RVTY | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 72.70 | 53.29 |
| Support Level | $110.17 | $19.36 |
| Resistance Level | $115.78 | $20.46 |
| Average True Range (ATR) | 4.18 | 0.68 |
| MACD | 1.41 | -0.05 |
| Stochastic Oscillator | 96.73 | 41.25 |
Price Performance
Historical ComparisonAbout RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.